- 1994 (x)
- Department of Chemical & Bimolecular Engineering (x)
- Search results
Search results
Show morePlasma water treatment (PWT) is an emerging water treatment technology that utilizes electrical discharges in gases to degrade aqueous contaminants. Prior work has demonstrated that PWT is capable of degrading perfluorooctanoic acid, a widespread contaminant that is unable to be degraded by denitrification or UV processes that wastewater facilities currently employ. In addition, unlike other approaches, PWT forms energetic species directly from water, eliminating the need for additional chemicals or catalysts. However, internal mechanisms within PWT treatment process, such as the production of different radical species are not well understood. Characterization of the species and their role in degradation is necessary to optimize the process. A challenge is that PWTs generate ultraviolet radiation, electrons, ions, and other non-equilibrium species, and these species are extremely short-lived and recombine or react within nanoseconds of formation. As a result, these species cannot be detected using analytical chemical techniques alone. In this work, we generated an argon-based, non-equilibrium plasma at the gas-liquid interface of aqueous solutions. Using PFOA as a model contaminant at environmentally-relevant concentrations from 0.02 mM to 1 mM, we demonstrate degradation with a maximum of 29% after 2 hours of treatment. To understand the degradation mechanism, we applied a chemical probe, terephthalic acid (TPA), which can specifically react with hydroxyl radicals (OH) and form a fluorescent compound, 2-hydroxyterephthalate (HTPA), that can be optically detected. While we observed the formation of OH, as the exposure to the plasma increased from 10 minutes to 4 hours, the intensity of the fluorescent peak was found to rapidly decrease. Using a control experiment, we show that the plasma is capable of degrading HTPA. These results indicate that chemical probes and their products are susceptible to species produced by the plasma which can compromise this technique. In the future, stable chemical probes or process conditions which avoid their degradation are required.
Show less
Show moreBecause of its β− and γ decay routes, 67Cu is a very promising radioisotope for use in theranostic cancer treatments. Currently, 67Cu is produced through the irradiation of either 68Zn or 67Zn in a cyclotron, a traditional nuclear reactor or a linear electron accelerator. Once formed, a small amount of copper (nanograms) has to be separated from the large amount of remaining zinc (grams) and undesired byproduct isotopes such as 66Ga, 67Ga, 64Cu, 61Cu, 58Co. Currently, such separations are performed in resin-packed columns and can require 3–4 h to purify a 5 g target. These procedures may involve multiple columns and require the target to be dissolved and reconstituted several times in different solutions and concentrations of acids. The complexity and length of resin-based separations combined with the 2.58-day half-life of 67Cu has caused a shortage of 67Cu for research and clinical trials.
Show less